Evidence map›Paper›PMID 31294380›Full record

ArticleJournal of the Canadian Association of Gastroenterology2019

The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn's and Colitis Canada.

Eric I Benchimol, Charles N Bernstein, Alain Bitton, Sanjay K Murthy, Geoffrey C Nguyen, Kate Lee, Jane Cooke-Lauder, Shabnaz Siddiq, Joseph W Windsor, Matthew W Carroll and 13 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the Canadian Association of Gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 75 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Virtual care in inflammatory bowel disease: Lessons learned in the CaNVAS-IBD Program.Canadian family physician Medecin de famille canadien · 2024
    Article
  17. Review
  18. The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive Summary.Journal of the Canadian Association of Gastroenterology · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 1 country.

Eric I BenchimolCanadian Gastro-Intestinal Epidemiology Consortium, Canada.ORCID 0000-0001-8855-3598
Charles N BernsteinCanadian Gastro-Intestinal Epidemiology Consortium, Canada.
Alain BittonCanadian Gastro-Intestinal Epidemiology Consortium, Canada.
Sanjay K MurthyCanadian Gastro-Intestinal Epidemiology Consortium, Canada.
Geoffrey C NguyenCanadian Gastro-Intestinal Epidemiology Consortium, Canada.
Kate LeeCrohn's and Colitis Canada, Toronto, Ontario, Canada.
Jane Cooke-LauderBataleur Enterprises Inc, Toronto, Ontario, Canada.
Shabnaz SiddiqChildren's Hospital of Eastern Ontario IBD Centre, Department of Pediatrics and School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Joseph W WindsorCanadian Gastro-Intestinal Epidemiology Consortium, Canada.
Matthew W CarrollCanadian Gastro-Intestinal Epidemiology Consortium, Canada.
Stephanie CowardCanadian Gastro-Intestinal Epidemiology Consortium, Canada.
Wael El-MataryCanadian Gastro-Intestinal Epidemiology Consortium, Canada.
Anne M GriffithsSickKids IBD Centre, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Ontario, Canada.
Jennifer L JonesCanadian Gastro-Intestinal Epidemiology Consortium, Canada.
M Ellen KuenzigCanadian Gastro-Intestinal Epidemiology Consortium, Canada.ORCID 0000-0002-3984-8426
Lawrence LeeOttawa Hospital Research Institute, Department of Medicine and School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
David R MackCanadian Gastro-Intestinal Epidemiology Consortium, Canada.
Mina MawaniCrohn's and Colitis Canada, Toronto, Ontario, Canada.
Anthony R OtleyCanadian Gastro-Intestinal Epidemiology Consortium, Canada.
Harminder SinghCanadian Gastro-Intestinal Epidemiology Consortium, Canada.
Laura E TargownikCanadian Gastro-Intestinal Epidemiology Consortium, Canada.
Adam V WeizmanMount Sinai Hospital Centre for IBD, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Gilaad G KaplanCanadian Gastro-Intestinal Epidemiology Consortium, Canada.
University of Ottawa · CAUniversity of Manitoba · CAUniversity of Calgary · CACrohn's and Colitis Canada · CADalhousie University · CAMount Sinai Hospital · CAMcGill University Health Centre · CAUniversity of Alberta · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Canada has among the highest rates of IBD in the world, and the number of people living with these disorders is growing rapidly. This has placed a high burden on the health care system and on the Canadian economy-a burden that is only expected to grow in the future. It is important to understand IBD and its impact on Canadian society in order to appropriately plan for health care expenditures, reduce the burden on patients and their families, and improve the quality of life for those afflicted with IBD. In Canada, there is a lack of public awareness of the impact of Crohn's disease and ulcerative colitis. Raising awareness is crucial to reducing the social stigma that is common with these diseases and to help individuals maximize their overall quality of life. A better public understanding of IBD can also help to raise and direct funds for research, which could lead to improved treatments and, ultimately, to a cure. This report from Canadian clinicians and researchers to Crohn's and Colitis Canada makes recommendations aimed at the public, policy-makers, scientific funding agencies, charitable foundations and patients regarding future directions for advocacy efforts and areas to emphasize for research spending. The report also identifies gaps in knowledge in the fields of clinical, health systems and epidemiological research.

Indexed as

CostsCrohn’s diseaseInflammatory bowel diseasePrevalenceQuality of lifeUlcerative colitis

Identifiers

PMID31294380
PMCPMC6512240
OpenAlexW2899378522

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.